Wednesday, August 15, 2018 1:57:57 PM
Analyst Actions: Maxim Group Downgrades Cytori Therapeutics Inc to Hold From Buy
9:36 AM ET, 08/15/2018 - MT Newswires
09:36 AM EDT, 08/15/2018 (MT Newswires) -- Cytori Therapeutics Inc's (CYTX) average rating among analysts is a buy, with an average price target of $14.
Price: 0.38, Change: -0.02, Percent Change: -5.00
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM